National Institutes of Biotechnology Malaysia (NIBM) is a consortium of three national biotechnology
institutes– Malaysian Institute of Pharmaceuticals & Nutraceuticals (IPHARM), Agro-Biotechnology
Institute Malaysia (ABI), and Malaysia Genome & Vaccine Institute (MGVI), established
on 27 January 2012 as a Company Limited by Guarantee (CLG), an autonomous
not-for-profit entity to administer IPHARM, ABI and MGVI.